Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma-Reference-Cited by-同舟云学术

Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma

Published:2020-09-26 Issue:3 Volume:78 Page:381-391
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Yamashita Satoshi¹²,Abe Hiroyuki¹,Kunita Akiko¹,Yamashita Hiroharu²,Seto Yasuyuki²,Ushiku Tetsuo¹^ORCID

Affiliation:

1. Department of Pathology Graduate School of Medicine University of Tokyo TokyoJapan

2. Department of Gastrointestinal Surgery Graduate School of Medicine University of Tokyo Tokyo Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14230

Reference32 articles.

1. Neuroendocrine Carcinoma of the Stomach

2. Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute

3. La RosaS RindiG SolciaEet al.Gastric neuroendocrine neoplasms. In WHO Classification of Tumours Editorial Board eds. World Health Organization classification of tumours. Digestive system tumours 5th edn. Lyon: IARC Press 2019; 104–109.

4. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

5. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 expression, tumor-infiltrating lymphocytes, and mismatch repair proteins status in digestive neuroendocrine neoplasms: exploring their potential role as theragnostic and prognostic biomarkers;Virchows Archiv;2024-05-21

2. Complete response induced by nivolumab monotherapy in gastric neuroendocrine carcinoma: a case report;International Cancer Conference Journal;2024-05-21

3. Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis;Cancer Medicine;2024-02

4. Association of PD-L1 Expression with Clinicopathologic Characters in Gastric Cancer: A Comprehensive Meta-analysis;Current Medicinal Chemistry;2023-10-27

5. Deep and Repeated Response to Trastuzumab Deruxtecan in a Patient With Human Epidermal Growth Factor Receptor 2–Amplified Large-Cell Neuroendocrine Carcinoma With Brain Metastases: A Case Report;JCO Precision Oncology;2023-09